MEC Basic Full List ViewBy pinki@katapult.biz / February 16, 2025 MEC Basic Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignant Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Oral Cancer Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title Type of Media — Video Document Audio Events — 2024 California Cancer Consortium Conference (CCC) 2024 MCM 2024 MCM 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS 2024 MaTOS Lungs 2025 PRIMO Search Everything « 1 … 57 58 59 60 61 62 » Updates in Multiple Myeloma 12 months in 10 minutes Aaron Rosenberg, MD, MS View PDF State of the art CAR-T cell therapy in lymphoma Tanya Siddiqi, MD View PDF Urothelial Cancers- New Strategies Sandy Srinivas, MD View PDF Pharmacokinetics of Anti-Cancer Agents in the CNS Tim Synold, PharmD View PDF What New in Hematopoietic Stem Cell Transplantation Joseph M. Tuscano, MD View PDF TNBCBRCA Mutated Tumors Yuan Yuan, MD, PhD View PDF Multiple Myeloma Transplant and Non-transplant Modalities Sikander Ailawadhi, MD View PDF Immunotherapy for Breast Aurelio B. Castrellon, MD View PDF Combination Immunotherapy for Lung Cancer Scott Antonia, MD, PhD View PDF Targeted Agents and Chemotherapy in Gynecologic Malignanciess in 2018 Gerado Colon-Otero, MD View PDF Squamous Cell Carcinoma: What are the Standards and Potential Pathways in Development Luis Corrales-Rodriguez, MD View PDF Treatment of Early-Stage HER2+ Breast Cancer Chau T. Dang, MD View PDF Acute Myeloid and Lymphoid Leukemias Hugo F. Fernandez, MD View PDF Prostate Cancer Management Mayer Fishman, MD, PhD View PDF Ovarian cancer: Contemporary Management & Clinical Trial Endpoint Considerations Thomas J. Herzog, MD View PDF Immunotherapy in Head and Neck Cancer and MSI in Solid Tumors Brian Hunis, MD, MBA View PDF CLL & CML Mohamed A. Kharfan-Dabaja, MD, MBA View PDF Colorectal Cancer: Novel Insights Richard Kim, MD View PDF Immunotherapy for the Treatment of Kidney and Bladder Cancer Alan J. Koletsky, MDky, MD View PDF Novel Therapies in Metastatic Kidney Cancer Primo N. Lara, Jr., MD View PDF Melanoma: What Else Beyond Checkpoint Inhibitor Pathway? Jose Lutzky, MD, FACP View PDF Supportive Care Reality vs. Perception Jessica MacIntyre, ARNP, NP-C, AOCNP View PDF Cancer Treatment Induced Bone Loss (CTIBL)_ RANK Ligand, Bisphosphonate, Anti-angiogenesis, and More Robert E. Marx, DDS View PDF Integrative Oncology: Evidence-Based Supportive Care for Patients during Treatment and Survivorship Ashwin Mehta, MD, PhD View PDF Familial Hereditary Symdromes in High-risk Breast Cancer Patients_ Genetic Counseling Louise Morrell, MD View PDF Marijuana Use in Cancer: Myths and Reality Dov Pickholtz, DO View PDF Other Driver Mutations: cMET, B-RAF, RET, NTRK Luis E. Raez, MD, FACP, FCCP View PDF Pancreatic, Biliary, and HCC Update Caio Max S. Rocha Lima, MD View PDF EGFR & ALK: Where are We Now Edgardo S. Santos, MD, FACP View PDF Health, Wellness and Cancer Prevention Orlando E. Silva, MD View PDF
